Cineworld’s shares, which have already more than tripled from a low of 25p last October, jumped by another 4% early this week, says Naomi Ackerman in the Evening Standard: box-office receipts for the first weekend after cinemas were allowed to reopen in the UK “smashed expectations”. Not only has attendance “soared”, but revenues were increased further by punters “splashing out on popcorn and other treats”. All this raises hopes that the chain can recover from a disastrous 2020, when it suffered an “eye-watering” £1.7bn loss and was forced to seek a £900m bailout from investors.
It’s not just the UK powering Cineworld’s recovery, says James Warrington in CityAM. The reopening of 167 cinemas in the US means that 97% of its screens are now active, while restrictions are due to be relaxed in Poland and Israel. CEO Mooky Greidinger expects a “good recovery in attendance over the coming months” thanks to a “full slate of films” including action-thriller F9, which has already had “record breaking” success in Asia. While cinemas face intensifying competition from the rise of streaming services, Cineworld has signed an “exclusive deal” with Warner Bros securing a 45-day window of exclusivity following films’ release from next year.
The streamers strike back
Still, the threat from Amazon and Netflix isn’t going away, says The Wall Street Journal. Amazon is nearing a deal to buy the Hollywood studio MGM Holdings for almost $9bn. If the tie-up goes ahead it “would mark Amazon’s second-largest acquisition in history after its $13.7bn purchase of Whole Foods in 2017”. It would also highlight “the premium that content is commanding” as streaming wars “force consolidation and drive bigger players to bulk up with assets that help them compete”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Amazon’s shareholders should beware, says Nils Pratley in The Guardian. It’s true that any Amazon takeover of MGM will “probably get a regulatory thumbs up”, as owning the film studio behind the James Bond franchise “does not create a licence to kill when the competition includes beasts the size of Comcast, AT&T and Disney”. However, Amazon now runs an “astonishing” span of businesses, including computing and supermarkets, so there is a very real risk that its “many adventures in unrelated fields” means that it “ties itself into knots” and ends up as a “confused conglomerate”.
The size of Amazon’s $9bn offer for MGM has “astonished” many rival studios, say Brent Lang and Cynthia Littleton in Variety. The problem for Amazon is that while MGM has an “extensive library of over 4,000 film titles”, including classics such as Four Weddings and a Funeral and The Silence of the Lambs, many of the most popular ones have already been heavily “exploited”. Worse, MGM’s deal with Barbara Broccoli and Michael Wilson gives them “final say” over marketing and distribution decisions related to the Bond franchise, complicating any plans to debut Bond films on Amazon Prime or create spin-off series.
-
Dividend heroes: the investment trusts that have increased their dividends for 20+ yearsInvestment trusts can be a good option for income-focused investors – but which trusts have consistently increased their dividends over the past 20 years?
-
Six reasons not to top up your state pensionA deadline to buy National Insurance credits and top up your state pension is fast approaching. Here’s why it may not be worth it for some people
-
Why CEOs deserve a pay riseOpinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
-
Rolls-Royce stock jumps 15% – could it climb further?Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
-
The power of private marketsInterview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Global investors have overlooked these top tips in emerging marketsOpinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
-
King Coal has not been dethroned yet — should you buy?The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
-
It’s time to start buying Europe again, says Merryn Somerset WebbOpinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fadesFood-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
